Login/Sign Up
Odihale 50 Inhaler 120 MDI belongs to the class of medicines called respiratory stimulants. It is used in the treatment of asthma and chronic obstructive pulmonary diseases (COPD). Asthma is a long-term serious health condition occurring due to the narrowing and swelling of the bronchial airways in the lungs, thus causing difficulty in breathing. Symptoms may include shortness of breath or wheezing (whistling sound while breathing). COPD is a group of long-term lung diseases with emphysema (shortness of breath) and chronic bronchitis (inflammation of the lining of bronchial tubes) causing restricted airways. Odihale 50 Inhaler 120 MDI helps reduce symptoms of asthma and COPD.
Odihale 50 Inhaler 120 MDI contains Fluticasone Furoate (inhaled corticosteroid) and Vilanterol (long-acting beta-agonists-LABA). Vilanterol belongs to the class of bronchodilators that works by relaxing muscles and opening the airways of the lungs. Fluticasone Furoate works by inhibiting the release of certain chemicals in the body that cause inflammatory reactions. Thereby providing relief from sneezing, shortness of breath, or wheezing.
Odihale 50 Inhaler 120 MDI is for inhalation use only. It should be used as advised by your doctor. The dose and duration of medicine will be recommended by your doctor based on your medical condition. Odihale 50 Inhaler 120 MDI may cause certain side effects such as sore throat, sneezing, headache, cough, low fever, chest tightness, stuffy nose, a fungal infection in the mouth, nausea, stomach upset, dizziness, nervousness, or vomiting. Most of these side effects do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
Odihale 50 Inhaler 120 MDI should be avoided if you are allergic to any of its components. This medicine should be avoided in patients with life-threatening conditions of asthma or COPD. Inform your doctor if you have any other lung infections, glaucoma, cataracts, osteoporosis (weak bones), tuberculosis, or kidney/liver problems or take any immunosuppressant medicines before taking this medicine. If you are pregnant or breastfeeding, inform your doctor before starting treatment with Odihale 50 Inhaler 120 MDI. If you experience severe difficulty in breathing or wheezing while using Odihale 50 Inhaler 120 MDI, please consult your doctor immediately so that alternative medicine may be prescribed. Odihale 50 Inhaler 120 MDI is not recommended for children below 12 years of age.
Odihale 50 Inhaler 120 MDI is a combination medicine that contains Fluticasone Furoate (inhaled corticosteroid) and Vilanterol (LABA). Vilanterol belongs to the class of bronchodilators that works by relaxing muscles and opening the airways of the lungs. Fluticasone Furoate works by inhibiting the release of certain chemicals in the body that cause inflammatory reactions. Odihale 50 Inhaler 120 MDI also helps reduce exacerbations in patients suffering from COPD.
Odihale 50 Inhaler 120 MDI should be avoided if you are allergic to any of its components. Inform your doctor if you have any other lung infections, glaucoma, cataracts, osteoporosis (weak bones), tuberculosis, kidney/liver disease, or if you are taking any immunosuppressant medicines, as it can lead to serious infections. Regular monitoring of potassium levels and blood sugar levels is recommended while taking Odihale 50 Inhaler 120 MDI. If you are pregnant or breastfeeding, inform your doctor before starting treatment with Odihale 50 Inhaler 120 MDI. Sometimes, this medicine may worsen asthma symptoms in some patients. If you experience severe difficulty in breathing or wheezing, please consult a doctor immediately so that alternative medicine may be prescribed. Odihale 50 Inhaler 120 MDI is not recommended for children below 12 years of age.
Drug-Drug Interactions: Odihale 50 Inhaler 120 MDI may interact with bronchodilators (salbutamol, aminophylline, theophylline), steroids (budesonide, prednisone, mometasone, beclomethasone), heart-related medicines (sotalol, digoxin, disopyramide, procainamide, quinidine), drugs used to lower high blood pressure (atenolol, metoprolol, propranolol), medicines to induce labor (oxytocin), antithyroid agent (levothyroxine), antidepressants (imipramine, amitriptyline, isocarboxazid, phenelzine), antifungals (itraconazole, ketoconazole), HIV medicines (atazanavir, ritonavir, nelfinavir, indinavir, cobicistat, saquinavir) and antiparkinson drug (levodopa).
Drug-Food Interactions: Odihale 50 Inhaler 120 MDI may interact with grapefruit and grapefruit juice. Therefore, avoid intake of grapefruit or its juice with Odihale 50 Inhaler 120 MDI as it may lead to severe adverse effects.
Drug-Disease Interactions: If you have high blood pressure, diabetes, chest or lungs infection, hyperthyroidism (overactive thyroid), hypokalaemia (low potassium levels in the blood), glaucoma, cataracts, osteoporosis (weak bones), tuberculosis, heart, liver or adrenal gland problems, inform your doctor before taking Odihale 50 Inhaler 120 MDI.
Asthma: Asthma is a long-term serious health condition occurring due to the narrowing and swelling of the bronchial airways in the lungs, thus causing difficulty in breathing. The symptoms may include chest tightness, wheezing (whistling sound while breathing), shortness of breath, and cough, especially at night. The treatment for asthma includes medication, breathing exercises, and self-care.
Chronic obstructive pulmonary disease (COPD): COPD is a group of long-term lung diseases with emphysema (shortness of breath) and chronic bronchitis (inflammation of the lining of bronchial tubes) causing restricted airways. The symptoms include chronic cough, shortness of breath, or wheezing (whistle sound while breathing). It can occur due to smoking tobacco, and long-term exposure to fumes and chemicals may lead to COPD.
About Odihale 50 Inhaler 120 MDI
Odihale 50 Inhaler 120 MDI belongs to the class of medicines called respiratory stimulants. It is used in the treatment of asthma and chronic obstructive pulmonary diseases (COPD). Asthma is a long-term serious health condition occurring due to the narrowing and swelling of the bronchial airways in the lungs, thus causing difficulty in breathing. Symptoms may include shortness of breath or wheezing (whistling sound while breathing). COPD is a group of long-term lung diseases with emphysema (shortness of breath) and chronic bronchitis (inflammation of the lining of bronchial tubes) causing restricted airways. Odihale 50 Inhaler 120 MDI helps reduce symptoms of asthma and COPD.
Odihale 50 Inhaler 120 MDI contains Fluticasone Furoate (inhaled corticosteroid) and Vilanterol (long-acting beta-agonists-LABA). Vilanterol belongs to the class of bronchodilators that works by relaxing muscles and opening the airways of the lungs. Fluticasone Furoate works by inhibiting the release of certain chemicals in the body that cause inflammatory reactions. Thereby providing relief from sneezing, shortness of breath, or wheezing.
Odihale 50 Inhaler 120 MDI is for inhalation use only. It should be used as advised by your doctor. The dose and duration of medicine will be recommended by your doctor based on your medical condition. Odihale 50 Inhaler 120 MDI may cause certain side effects such as sore throat, sneezing, headache, cough, low fever, chest tightness, stuffy nose, a fungal infection in the mouth, nausea, stomach upset, dizziness, nervousness, or vomiting. Most of these side effects do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
Odihale 50 Inhaler 120 MDI should be avoided if you are allergic to any of its components. This medicine should be avoided in patients with life-threatening conditions of asthma or COPD. Inform your doctor if you have any other lung infections, glaucoma, cataracts, osteoporosis (weak bones), tuberculosis, or kidney/liver problems or take any immunosuppressant medicines before taking this medicine. If you are pregnant or breastfeeding, inform your doctor before starting treatment with Odihale 50 Inhaler 120 MDI. If you experience severe difficulty in breathing or wheezing while using Odihale 50 Inhaler 120 MDI, please consult your doctor immediately so that alternative medicine may be prescribed. Odihale 50 Inhaler 120 MDI is not recommended for children below 12 years of age.
₹691.2*
MRP ₹768
10% off
₹652.8*
MRP ₹768
15% CB
₹115.2 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Online payment accepted
Provide Delivery Location
Whats That
Online payment accepted
Uses of Odihale 50 Inhaler 120 MDI
Medicinal Benefits
Odihale 50 Inhaler 120 MDI is a combination medicine that contains Fluticasone Furoate (inhaled corticosteroid) and Vilanterol (LABA). Vilanterol belongs to the class of bronchodilators that works by relaxing muscles and opening the airways of the lungs. Fluticasone Furoate works by inhibiting the release of certain chemicals in the body that cause inflammatory reactions. Odihale 50 Inhaler 120 MDI also helps reduce exacerbations in patients suffering from COPD.
Side Effects of Odihale 50 Inhaler 120 MDI
Directions for Use
Storage
Drug Warnings
Odihale 50 Inhaler 120 MDI should be avoided if you are allergic to any of its components. Inform your doctor if you have any other lung infections, glaucoma, cataracts, osteoporosis (weak bones), tuberculosis, kidney/liver disease, or if you are taking any immunosuppressant medicines, as it can lead to serious infections. Regular monitoring of potassium levels and blood sugar levels is recommended while taking Odihale 50 Inhaler 120 MDI. If you are pregnant or breastfeeding, inform your doctor before starting treatment with Odihale 50 Inhaler 120 MDI. Sometimes, this medicine may worsen asthma symptoms in some patients. If you experience severe difficulty in breathing or wheezing, please consult a doctor immediately so that alternative medicine may be prescribed. Odihale 50 Inhaler 120 MDI is not recommended for children below 12 years of age.
Therapeutic Class
Drug-Drug Interactions Checker List
Diet & Lifestyle Advise
Habit Forming
Special Advise
Disease/Condition Glossary
Asthma: Asthma is a long-term serious health condition occurring due to the narrowing and swelling of the bronchial airways in the lungs, thus causing difficulty in breathing. The symptoms may include chest tightness, wheezing (whistling sound while breathing), shortness of breath, and cough, especially at night. The treatment for asthma includes medication, breathing exercises, and self-care.
Chronic obstructive pulmonary disease (COPD): COPD is a group of long-term lung diseases with emphysema (shortness of breath) and chronic bronchitis (inflammation of the lining of bronchial tubes) causing restricted airways. The symptoms include chronic cough, shortness of breath, or wheezing (whistle sound while breathing). It can occur due to smoking tobacco, and long-term exposure to fumes and chemicals may lead to COPD.